We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Biosimilars battle rages on, Amgen fights both sides.
- Authors
Senior, Melanie
- Abstract
The article reports that Swiss global health-care company F.Hoffmann-La Roche Ltd. has purchased two biotech giant including Amgen Inc. of Thousand Oaks, California, and Genentech Inc. of S. San Francisco, California to substitute brand name biologics for cheaper generic versions. It further discusses the plans of Amgen to launch its own biosimilars.
- Subjects
SAN Francisco (Calif.); BIOTECHNOLOGY; F. Hoffmann-La Roche Ltd.; AMGEN Inc.; GENENTECH Inc.
- Publication
Nature Biotechnology, 2013, Vol 31, Issue 4, p269
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0413-269